Encompass Health Debt to Equity Ratio 2010-2024 | EHC

Current and historical debt to equity ratio values for Encompass Health (EHC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Encompass Health debt/equity for the three months ending March 31, 2024 was 1.14.
Encompass Health Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $3.87B $2.36B 1.64
2023-12-31 $3.85B $2.26B 1.71
2023-09-30 $3.82B $2.15B 1.78
2023-06-30 $3.84B $2.02B 1.91
2023-03-31 $3.82B $1.93B 1.99
2022-12-31 $3.81B $1.83B 2.09
2022-09-30 $3.77B $1.71B 2.20
2022-06-30 $4.58B $2.50B 1.83
2022-03-31 $4.50B $2.45B 1.84
2021-12-31 $4.51B $2.36B 1.91
2021-09-30 $4.46B $2.26B 1.97
2021-06-30 $4.44B $2.18B 2.04
2021-03-31 $4.50B $2.04B 2.20
2020-12-31 $4.48B $1.97B 2.27
2020-09-30 $4.72B $1.90B 2.49
2020-06-30 $4.67B $1.83B 2.55
2020-03-31 $4.34B $1.80B 2.42
2019-12-31 $4.39B $1.69B 2.59
2019-09-30 $4.72B $1.67B 2.82
2019-06-30 $4.23B $1.58B 2.67
2019-03-31 $3.97B $1.62B 2.45
2018-12-31 $3.62B $1.56B 2.32
2018-09-30 $3.55B $1.58B 2.24
2018-06-30 $3.59B $1.50B 2.39
2018-03-31 $3.50B $1.44B 2.43
2017-12-31 $3.47B $1.40B 2.49
2017-09-30 $3.51B $1.37B 2.56
2017-06-30 $3.52B $1.32B 2.66
2017-03-31 $3.73B $0.98B 3.80
2016-12-31 $3.75B $0.93B 4.04
2016-09-30 $3.72B $0.91B 4.07
2016-06-30 $3.78B $0.85B 4.45
2016-03-31 $3.78B $0.82B 4.59
2015-12-31 $3.83B $0.78B 4.91
2015-09-30 $3.46B $0.79B 4.38
2015-06-30 $2.71B $0.77B 3.54
2015-03-31 $2.94B $0.64B 4.59
2014-12-31 $2.77B $0.62B 4.47
2014-09-30 $2.20B $0.59B 3.71
2014-06-30 $2.02B $0.56B 3.64
2014-03-31 $2.06B $0.48B 4.27
2013-12-31 $2.07B $0.47B 4.41
2013-09-30 $2.12B $0.44B 4.78
2013-06-30 $2.12B $0.39B 5.40
2013-03-31 $2.17B $0.22B 9.70
2012-12-31 $2.02B $0.40B 5.01
2012-09-30 $2.10B $0.36B 5.90
2012-06-30 $2.02B $0.29B 6.89
2012-03-31 $2.06B $0.24B 8.73
2011-12-31 $2.07B $0.20B 10.27
2011-09-30 $2.12B $0.15B 13.96
2011-06-30 $2.28B $0.10B 23.61
2011-03-31 $2.41B $0.07B 33.32
2010-12-31 $2.37B $-0.00B -1079.23
2010-09-30 $2.58B $-0.78B -3.30
2010-06-30 $2.57B $-0.82B -3.15
2010-03-31 $2.58B $-0.86B -2.99
2009-12-31 $2.58B $-0.90B -2.87
2009-09-30 $2.68B $-0.92B -2.90
2009-06-30 $2.94B $-1.05B -2.80
2009-03-31 $2.97B $-1.04B -2.84
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.608B $4.801B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.827B 10.78
Quest Diagnostics (DGX) United States $16.063B 16.60
DaVita (DVA) United States $11.923B 14.81
Chemed (CHE) United States $8.132B 25.20
Elanco Animal Health (ELAN) United States $6.597B 17.11
Option Care Health (OPCH) United States $5.235B 19.82
RadNet (RDNT) United States $4.632B 96.45
Amedisys (AMED) United States $3.202B 22.68
Astrana Health (ASTH) United States $2.666B 36.05
Addus HomeCare (ADUS) United States $2.179B 28.20
LifeStance Health (LFST) United States $2.095B 0.00
U.S Physical Therapy (USPH) United States $1.424B 38.10
Pennant (PNTG) United States $0.789B 41.67
Aveanna Healthcare Holdings (AVAH) United States $0.677B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00